LIBLICENSE-L Archives

LibLicense-L Discussion Forum

LIBLICENSE-L@LISTSERV.CRL.EDU

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
LIBLICENSE <[log in to unmask]>
Reply To:
LibLicense-L Discussion Forum <[log in to unmask]>
Date:
Wed, 18 Jan 2012 16:48:17 -0500
Content-Type:
text/plain
Parts/Attachments:
text/plain (23 lines)
From:  [log in to unmask]
Date: Wed, 18 Jan 2012 10:43:13 -0400

See this announcement of January 16th, in which Wiley joins a number
of other publishers in the "newish" OA-rapid publication journal
arena; go-live in Spring 2012:

http://www.4-traders.com/news/Major-Cancer-Societies-to-Support-New-Wiley-Open-Access-Journal--13970926/

"Wiley-Blackwell, the scientific, technical, medical and scholarly
publishing business of John Wiley & Sons, Inc., today announced the
launch of Cancer Medicine, a new Wiley Open Access journal. Cancer
Medicine is a peer reviewed, open access, interdisciplinary journal
providing rapid publication of cutting edge research from global
biomedical and clinical researchers across all the oncologic
specialties in cancer biology, clinical cancer research and cancer
prevention. The journal's promise of full global reach is reinforced
by its editorial leadership and support from prestigious journals and
societies. Cancer Medicine has unprecedented support from three major
cancer societies....."

Ann Okerson

ATOM RSS1 RSS2